ArticleEuropean journal of clinical pharmacology2012

Factor VII R353Q genetic polymorphism is associated with altered warfarin sensitivity among CYP2C9 *1/*1 carriers.

Liat Mlynarsky et al.PubMed ↗Publisher ↗

No numbers read from the abstract.